TrialClinical and translational science2019

Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects.

Susan Bellaire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.